About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
PODD - Insulet Corporation| Previous Close | $252.00 | Open | $250.00 |
| Volume | 532.1K | Market Cap | 16.614B |
| Yield | Last Dividend |
| Insulet Reports Full Year 2020 Revenue I... | 02/23/21 |
| ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with... | |
| Europe Wearable Injectors Market Set to ... | 02/23/21 |
| The Europe wearable injectors market is expected to reach US$ 3586.82 million in 2027 from US$ 1539.88 million in 2019. The market is estimated to gro... | |
| Tubeless Insulin Pump Market With Leadin... | 02/23/21 |
| An off-the-shelf report on Tubeless Insulin Pump Market which has been compiled after an in-depth analysis of the market trends prevailing across five... | |
| Insulet Earnings Report: Here???s what t... | 02/22/21 |
| Insulet announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| The Week Ahead In Biotech: J&J Vaccine A... | 02/20/21 |
| Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before picking up pa... | |
| Insulet to Present at Upcoming Investor ... | 02/08/21 |
| ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod?? ... | |
| Insulet???s Omnipod DASH?? System Now Av... | 01/18/21 |
| ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with... | |
| Insulet to Announce Fourth Quarter and F... | 01/11/21 |
| ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod?? ... | |
| The Daily Biotech Pulse: Urovant In M&A ... | 11/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 12) ALX... | |
| Insulin Infusion Pumps Market: Granular ... | 11/11/20 |
| The research and analysis conducted in Insulin Infusion Pumps report helps clients to predict investment in an emerging market, expansion of market sh... | |
| UBS Stick to Their Hold Rating for Insul... | 11/06/20 |
| UBS Stick to Their Hold Rating for Insulet | |
| Electronic Drug Delivery Systems Market ... | 11/05/20 |
| Global Electronic Drug Delivery Systems Market By Type (Electronic Wearable Infusion Pumps, Electronic Auto injectors, Electronic Injection Pens, Elec... | |
| Canaccord Genuity Stick to Their Hold Ra... | 11/05/20 |
| Canaccord Genuity Stick to Their Hold Rating for Insulet | |
| Insulet Reports Third Quarter 2020 Reven... | 11/04/20 |
| ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with... | |
| Insulet Raises Awareness for Diabetes Th... | 11/02/20 |
| ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with... | |
| Insulet Recognized as Global Impact Corp... | 10/29/20 |
| ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with... | |
| A 'premier growth' stock expert who's mo... | 10/28/20 |
| Summary List Placement If competition in corporate America and the stock market is always fierce, Ron Zibelli makes sure his portfolios follow the law... | |
| Insulet (NASDAQ:PODD) and Biostage (NASD... | 10/24/20 |
| Insulet (NASDAQ:PODD) and Biostage (OTCMKTS:BSTG) are both medical companies, but which is the better investment? We will compare the two businesses b... | |
| Financial Comparison: Biostage (OTCMKTS:... | 10/24/20 |
| Insulet (NASDAQ:PODD) and Biostage (OTCMKTS:BSTG) are both medical companies, but which is the superior investment? We will contrast the two companies... | |
| Latest Updated Report on Smart Diabetes ... | 10/23/20 |
| Diabetes management can be confused and frequently requires a multidisciplinary way to deal with assistance keep up ideal blood glucose control. Way o... | |
| Infusion Pumps Market Expected To Reach ... | 10/22/20 |
| This research report will give you deep insights about the Infusion Pumps Market and it will also help you in strategic decision making. The final res... | |
| Global Disposable Insulin Pumps Market t... | 10/22/20 |
| An insulin pump is a battery-powered device used to deliver rapid-acting insulin to the body through a catheter, replacing the need for periodic injec... | |
| Insulet Appoints Wayne A. I. Frederick, ... | 10/20/20 |
| ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with... | |
| The Daily Biotech Pulse: Vertex Pulls Pl... | 10/15/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 14) 10X... | |
| The Daily Biotech Pulse: Gilead, Lilly C... | 10/08/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-Week Highs Oct. 7) 10X ... | |
| Off-Body Wearable Injectors Market With ... | 10/06/20 |
| Wearable injectors are advanced drug delivery systems which are utilized to administer large volume of drugs. The devices adheres to patients' body su... | |
| Insulet to Announce Third Quarter 2020 F... | 10/05/20 |
| Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod?? Insulin Manageme... | |
| Wearable Injectors Market 2020 Research ... | 10/02/20 |
| Oct 02, 2020 (Market Insight Reports) -- This Global Wearable Injectors Market Research Report Forecast 2020-2025 is a valuable source of insightful d... | |
| The Daily Biotech Pulse: Amag Spikes On ... | 10/01/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 30) Ac... | |
| Insulin Pumps Market Overview and Scope ... | 10/01/20 |
| Global Insulin Pumps Market has been brewing up and influencing the international economy with respect to revenue, growth rate, sale, market share, an... | |
| Hold rating | 02/25/21 |
| Oppenheimer maintains Perform rating and raises Price Target from $235.00 to $277.00 | |
| Buy rating | 02/24/21 |
| SVB Leerink maintains Market Perform rating and raises Price Target from $255.00 to $275.00 | |
| Strong Buy rating | 02/24/21 |
| Raymond James maintains Outperform rating and raises Price Target from $282.00 to $296.00 | |
| Hold rating | 12/15/20 |
| Morgan Stanley maintains Equal-Weight rating and raises Price Target from $246.00 to $276.00 | |
| Date | 2021-02-23 (AMC) | Est. (EPS/Rev.) | ($0.04)/ 232.89M |
| Actual (EPS/Rev.) | $-0.26/ $246.10 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Spread and Condor Play | Sankar | 65.00 % | Subscribe |
| Wildsheeep | Pete | 33.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
